Cite
MLA Citation
S. Talayeva et al.. “Assessment of safety and tolerability of Herceptin subcutaneous administration in patients with HER2-positive early breast cancer: results of an open-label, randomized, multicenter, phase IIIB study.” Breast, vol. 32, n.d., pp. S27–. http://access.bl.uk/ark:/81055/vdc_100045079310.0x000011